Skip to main content
main-content

Zeitschrift

Hormones and Cancer

Hormones and Cancer OnlineFirst articles

18.06.2018 | Original Paper

Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer

Lung cancer is the most common cause of cancer-related deaths worldwide with non-small cell lung cancer (NSCLC) making up most of these cases. Males have poorer overall survival compared to women following a lung cancer diagnosis. Many studies …

14.06.2018 | Original Paper

The Influence of Menopausal Hormone Therapy and Potential Lifestyle Interactions in Female Cancer Development—a Population-Based Prospective Study

The past decades have seen contradictory research results on the health benefits and risks of menopausal hormone therapy (HT). In particular, long-term associations with overall cancer incidence and the potential interplay with other lifestyle …

09.06.2018 | Original Paper Open Access

Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome

In clinical practice, few prostate cancer (PCa) patients are associated with metabolic syndrome (MetS), while few others acquire MetS during treatment. Whether the treatment of PCa increases the occurrence of MetS remains to be confirmed. This …

07.05.2018 | Review

The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer

After nearly 20 years of research, it is now established that mutations within the estrogen receptor (ER) gene, ESR1, frequently occur in metastatic breast cancer and influence response to hormone therapy. Though early studies presented differing …

07.05.2018 | Original Paper

The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus

Apigenin is a flavonoid with well-documented anti-cancer properties; however, its mechanisms of action are still unclear. We previously identified apigenin as a potential phytoprogestin, a natural product with a chemical scaffold that interacts …

Aktuelle Ausgaben

Über diese Zeitschrift

Major areas of interest in cancer biology include:

-Cancer causation, metabolism, and hormone-dependence

-Disease progression, prevention, treatment, and resistance

-Translational studies dealing with novel therapeutic agents

-Hormone receptors and their co-regulatory molecules

-Hormonally infl uenced signaling pathways

-Nuclear and Steroid Hormone Receptors

-Adrenal, pituitary, and thyroid hormones

-Vitamin D

Weitere Informationen

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise